Shares of Dr. Reddy's Laboratories Ltd. 500124 inched down 0.51% to 1,318.75 Indian rupees Thursday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX ...

Dr. Reddy's Laboratories Limited has informed stock exchanges that the Phase III clinical trial evaluating the drug candidate ...

Dr Reddy’s Laboratories SA, a wholly-owned subsidiary of Dr Reddy’s Laboratories Ltd, has been advised by the IDMC to discontinue the phase III TACTI-004 trial of eftilagimod alfa in first-line ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.70% to 1,303.90 Indian rupees Friday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX Index ...

Stay informed with the Dr Reddys Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent stocks in the market. Stay on top of the game with our comprehensive ...

Discover key updates on Vodafone Idea, Wipro, Dr Reddy's, and more—track the latest stock moves and market opportunities now!

The Delhi High Court has upheld an order permitting Dr Reddy's Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk's appeal in the ongoing patent dispute ...

Dr Reddy's Laboratories announced that it has received the Establishment Inspection Report (EIR) on 4 March 2026 from the U.S. Food and Drug Administration (USFDA) for its formulations manufacturing ...

Dr Reddy's said the regulator has stated that it has now concluded its investigation into the anonymous allegations of ...

A division Bench of justices C. Hari Shankar and Om Prakash Shukla said that it did not find reason to interfere with a ...

Bears maintain strong control over the market despite the relief rally; hence, any upside bounce is unlikely to sustain amid ...